Skip to content
10-Q

Quarterly Report

CEREBAIN BIOTECH CORP.

0001477932-18-002503

← back to feed
Filed
May 15, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2018 · May 14, 2018 9.04M sh
Current Liabilities Q3 2018 · Mar 31, 2018 $2.75M
Current Liabilities Q3 2018 · Jun 30, 2017 $1.75M
Total Liabilities Q3 2018 · Mar 31, 2018 $5.32M
Total Liabilities Q3 2018 · Jun 30, 2017 $4.49M
Current Assets Q3 2018 · Mar 31, 2018 $125.46K
Current Assets Q3 2018 · Jun 30, 2017 $236.86K
Total Assets Q3 2018 · Mar 31, 2018 $125.46K
Total Assets Q3 2018 · Jun 30, 2017 $236.86K
Operating Cash Flow Q3 2018 · Mar 31, 2017 −$445.73K
Cash And Equivalents Q3 2018 · Mar 31, 2017 $517
Cash And Equivalents Q3 2018 · Jun 30, 2016 $20.25K
Sga Expense Q3 2018 · Mar 31, 2017 $439.05K
Sga Expense Q3 2018 · Mar 31, 2017 $1.27M
Rd Expense Q3 2018 · Mar 31, 2017 $58.9K
Rd Expense Q3 2018 · Mar 31, 2017 $190.37K
Net Income Q3 2018 · Mar 31, 2017 −$566.75K
Net Income Q3 2018 · Mar 31, 2017 −$15.45M